Genes Identified That Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Br...( Identifies potential clinical trial s...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Genes Identified That Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Brostallicin
Date:4/20/2009
Identifies potential clinical trial strategies for personalized approach to cancer treatment
SEATTLE, April 21 /PRNewswire-FirstCall/ -- Systems Medicine, LLC (SM), a wholly-owned subsidiary of Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC), presented data from a preclinical study, which utilized RNA interference (RNAi) and bioinformatics to identify genetic markers - "contexts of vulnerability" - that enhance the anti-tumor response to the experimental drug candidate brostallicin, at the 2009 American Association for Cancer Research (AACR) annual meeting in Denver, Colorado. "Contexts of vulnerability" refers to the genetic configuration in a patient's tumor that makes it susceptible to a specific drug thus providing the genetic rationale for targeted therapy. The study's objective was to identify molecular determinants of brostallicin's anti-tumor response that could guide clinical development and drug combination studies by incorporating an integrated pharmacogenomics approach. The study was conducted by SM in collaboration with the Translational Genomics Research Institute's Pharmaceutical Genomics Division in Scottsdale, Arizona.
"This study has identified certain patient groups which might be more likely to benefit from therapy with brostallicin and have been invaluable in assisting us in identifying promising clinical development strategies for future development of this novel drug candidate," said Jack Singer, M.D., Chief Medical Officer of CTI. "Ultimately, we believe this approach should shorten the clinical development time and increase the success rate by bringing us closer to being able to offer the right drug to the appropriate patient."
Brostallicin is a small-molecule chemotherapeutic agent with a unique mechanism of action -- it binds to the minor grooves located in the DNA double helix. To identify genes associated with cellular response to brostallicin, a high-throughput RNA interfe
'/>"/>
| SOURCE Cell Therapeutics, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives
2. Why Wait for an Anti-Aging Drug? Researchers Interviewed on CBS-TVs 60 MINUTES Discover Longevinex(R) Nutriceutical Matrix Activates 9-Fold More Longevity Genes than Plain Resveratrol
3. STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany
4. OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
5. Breakthrough Mapping of Alzheimers Genome Helps ID Four New Suspect Genes
6. Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeutic Programs
7. Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection
8. New Genes Found for Inflammatory Bowel Disease in Children
9. Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber
10. Cardiogenesis Announces Preliminary Clinical Results With the PHOENIX System Combining TMR + Stem Cells
11. NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression
Post Your Comments:
(Date:11/25/2009)...PRNewswire/ -- Cempra Pharmaceuticals Inc. today a... chief executive officer, will present at the Pipe...50 a.m. EST, December 1, 2009, at The New York Pal...ovide an overview of the company,s two leading ant...g-resistant pathogens including MRSA. ,, About...
(Date:11/25/2009)...Nov. 25 HeartWare Intern...g innovator and provider of less invasive, miniatu...zing the treatment of advanced heart failure, toda...or presentation at the 21st Annual Piper Jaffray H... December 2, 2009. The conference is being held at...
(Date:11/24/2009)...ire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX )...ortic disorders, announced today that it has filed...in, the patent infringement lawsuit brought agains... filed in the United States District Court in Indi...hat the stay remain in effect while the United Sta...
Breaking Medicine Technology:HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Hospital Improves Patient Experience by Adding Email and Web Access in Patient Rooms With Virtual Linux Desktops 50519 1Hospital Improves Patient Experience by Adding Email and Web Access in Patient Rooms With Virtual Linux Desktops 50519 2Hospital Improves Patient Experience by Adding Email and Web Access in Patient Rooms With Virtual Linux Desktops 50519 3Hospital Improves Patient Experience by Adding Email and Web Access in Patient Rooms With Virtual Linux Desktops 50519 4Hospital Improves Patient Experience by Adding Email and Web Access in Patient Rooms With Virtual Linux Desktops 50519 5CDYNE XML Web Services Help Organizations Comply with FTC Red Flags Rule 50516 1CDYNE XML Web Services Help Organizations Comply with FTC Red Flags Rule 50516 2CDYNE XML Web Services Help Organizations Comply with FTC Red Flags Rule 50516 3Air Force Chief Master Sergeant Rod McKinley 28U S Air Force Retired 29 Joins MicroTech as Vice President of Strategic Partnerships 12870 1Air Force Chief Master Sergeant Rod McKinley 28U S Air Force Retired 29 Joins MicroTech as Vice President of Strategic Partnerships 12870 2Air Force Chief Master Sergeant Rod McKinley 28U S Air Force Retired 29 Joins MicroTech as Vice President of Strategic Partnerships 12870 3...,osteoporosis receiving once-monthly Boniva(R) (ib...ncreases in bone mineral density (BMD) to those,re...), according to a new,study presented at the 29th ...d Mineral Research. The study, called MOTION (Mon...s iNtervention), is the first head-to-head non-inf...
...,V. Cheney Cardiovascular Institute and The Cather...Washington University host a cutting edge,Symposiu...e growing forces,of genomics and personalized medi...provide a valuable state-of-the-art update on the ...cs of atherosclerotic,cardiovascular disease, hear...
Other Medicine Technology:New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis 2New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis 3New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis 4Personalized Medicine - The Genomic Revolution in Cardiac Care 2Personalized Medicine - The Genomic Revolution in Cardiac Care 3(Date:11/28/2009)...ect circadian rhythm, , , FRIDAY, N...hat an internal body clock that goes on the fritz ...sorder in children. , The finding results from...dren with bipolar disorder, which can make people ... without the disorder. They linked variations in a...
(Date:11/27/2009)...wswire-FirstCall/ -- GSI Group Inc. (Pink Sheets: ...hnology products and semiconductor systems, today ...shareholders has been scheduled for Friday, April ...ll be announced in due course. As previously anno...rom Stephen Bershad, a holder of greater than ten ...
(Date:11/27/2009)...likins Ltd. today issued its latest biochemical an...hat the lethality of the virus has dropped from it...t outbreak in the spring of 2009 to resting non-ep...1 infectivity count, however, remains increased. ...27, 2009 -- Biotech firm Replikins Ltd., which has...
(Date:11/27/2009)...ire-FirstCall/ -- The Gymboree Corporation (Nasdaq...ill present at the NASDAQ OMX 23rd Investor Progra...don, England, on Wednesday, December 2, 2009, at 1... of The Gymboree Corporation,s presentation over t...ick on "Our Company" at the bottom of the page, go...
(Date:11/27/2009)...ov. 27 Team Garmin-Slipstream, the...d to ethical sporting and developing the next gene...it will become Team Garmin-Transitions with the ad...the team. Transitions Optical is the world,s leadi...most advanced photochromic technology in the wides...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3[0] Bipolar Disorder May Be Tied to Body Clock[0] GSI Group Calls Shareholders Meeting[0] Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased[0] The Gymboree Corporation to Present at NASDAQ OMX 23rd Investor Program[0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor
...hn W. Walsh, president of the COPD,Foundation, wil...al,Respiratory Congress of the American Associatio...L. AARC is a 43,000-member association,representin...tic fibrosis, and Chronic Obstructive Pulmonary,Di...
...t. 25 Gentiva Health,Services, Inc. (Nasdaq: GTI...e home health and related services, announced toda...to 10:50 a.m., Wednesday, November 7,2007 at the C...essed by visiting http://investors.gentiva.com/ev...
...n its first-ever,single-topic special issue, the H...mber 2007 issue offers advice aimed at unscramblin...y eating. Based on the latest,research on nutritio... have to a magic bullet,against heart disease. To ...
...., Oct. 25 The Board of,Directors of American Phy...,has declared a cash dividend of 10 cents per comm...s of record at the close of business on December 1...nal provider of medical,professional liability ins...
...asimo provides unique benefits in pulse oximetry, ...tional hemodynamic monitoring IRVINE, Calif., Oct...f,Pulse CO-Oximetry and Read-Through Motion and Lo...rican Society of,Anesthesiology (ASA) Annual Meeti...
..., Oct. 25 Thoratec,Corporation (Nasdaq: THOR ), ... disease, today announced that it will report its ...2007 on Thursday, November 1. The company will ho...30 a.m., Eastern Daylight Time), Thursday,November...
Other Medicine News:Health News:Alpha-1 Foundation President to Give Keynote Address at 53rd Annual Respiratory Congress of the AARC Foundation and Activities 2Health News:Alpha-1 Foundation President to Give Keynote Address at 53rd Annual Respiratory Congress of the AARC Foundation and Activities 3Health News:Gentiva(R) Health Services to Present November 7 at CIBC Healthcare Conference in New York 2Health News:Gentiva(R) Health Services to Present November 7 at CIBC Healthcare Conference in New York 3Health News:All About Heart-Healthy Eating: The Harvard Heart Letter Devotes an Issue to Nutrition 2Health News:Breaking Studies - Masimo's Technologies the Focus of Multiple Clinical Studies at Last Week's American Society of Anesthesiologists' Annual Meeting 2Health News:Breaking Studies - Masimo's Technologies the Focus of Multiple Clinical Studies at Last Week's American Society of Anesthesiologists' Annual Meeting 3Health News:Breaking Studies - Masimo's Technologies the Focus of Multiple Clinical Studies at Last Week's American Society of Anesthesiologists' Annual Meeting 4Health News:Breaking Studies - Masimo's Technologies the Focus of Multiple Clinical Studies at Last Week's American Society of Anesthesiologists' Annual Meeting 5Health News:Breaking Studies - Masimo's Technologies the Focus of Multiple Clinical Studies at Last Week's American Society of Anesthesiologists' Annual Meeting 6Health News:Thoratec Schedules Third Quarter Conference Call, Webcast 2Alpha-1 Foundation President to Give Keynote Address at 53rd Annual Respiratory Congress of the AARC Foundation and ActivitiesGentiva(R) Health Services to Present November 7 at CIBC Healthcare Conference in New YorkAll About Heart-Healthy Eating: The Harvard Heart Letter Devotes an Issue to NutritionAmerican Physicians Capital, Inc. Declares Fourth Quarter Cash Dividend of 10 Cents Per Common ShareBreaking Studies - Masimo's Technologies the Focus of Multiple Clinical Studies at Last Week's American Society of Anesthesiologists' Annual MeetingThoratec Schedules Third Quarter Conference Call, Webcast
...PROVISION Surgical Helmet System from DePuy offers...tion. This system helps meet OSHA recommendations ...fluids, while creating a new standard for comfort....SION Helmet System from DePuy, is a personal prote...
Single Disc Electrodes
Thru-the-Lens Headlight Video Imaging System
Ring Electrodes
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |